On Thursday, a judge in Northern California District Court rejected a motion by Facebook for the dismissal of a lawsuit which accuses the social network of violation of user privacy via its photo-tagging feature.
By turning down Facebook's motion to have the lawsuit dismissed, US District Judge James Donato has given permission for the lawsuit to proceed. The lawsuit chiefly revolves around Facebook's use of facial recognition technology, without users' consent, for its photo-tagging feature.
According to the lawsuit, which is in the form of a class-action complaint by three Facebook users from Illinois, Facebook's violation of user privacy is rooted in the fact that the company scans the faces of its users without explicit permission, and enables others to "tag" them in photos.
The plaintiffs have sued Facebook under an Illinois state law, the Biometric Information Privacy Act (BIPA), which regulates the manner in which 'biometric identifiers' -- including iris scans and 'face geometry' -- are used by companies. A violation of the law involves penalties of $1,000 or $5,000.
In his ruling against Facebook, Judge Donato agreed with the argument in the lawsuit that Facebook's scanning and tagging feature can be considered as the use of 'biometric identifier' covered by the Illinois BIPA statute.
If you believe spanking could help your child become well behaved or less naughty, then you are wrong. People usually indulge in spanking when they want to punish their children for misconduct.
Spanking is an act of slapping children on...
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies...
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel's...
During the course of a recent interview with The Verge, automaker Volvo's Trent Victor - the company's senior technical leader of crash avoidance - said that Volvo has efforts underway to introduce an autonomous driving technology better than...
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in...
Tech giant Google has revealed in a recent announcement that its latest Nik Collection of photo...
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won't seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said...
New reports surfaced on the Internet this past weekend...
In a recent announcement, California Great America said...
In a "backer-only" update posted to the Kickstarter page...
On Thursday, bigwig South Korean electronics firm...
© 2011 AustrianTribune - Tribune Online Services. All times CET (GMT + 1.00).